Martin Krsak, MD
Assistant Professor, Medicine-Infectious Disease

Photo
Medical School:
  • MD, Comenius University School of Medicine (2005)
Graduate School :
  • MSc, Tufts University (2014)
Internship:
  • Caritas Carney Hospital Program (2009)
Residency:
  • Caritas Carney Hospital Program, Internal Medicine (2011)
Fellowships:
  • Tufts Medical Center Program, Infectious Disease (2014)
Department: Medicine-Infectious Disease

Research Interests

HIV, viral hepatitis and other infections in patients with substance use disorders; substance use disorders/addiction medicine; COVID-19

Teaching

  • Assistant Professor (2015)
    School of Medicine, Medicine
    HIV, viral hepatitis and other infections in patients with substance use disorders

Publications

  • Franco-Paredes C, Ghandnoosh N, Latif H, Krsak M, Henao-Martinez AF, Robins M, Vargas Barahona L, Poeschla EM. Decarceration and community re-entry in the COVID-19 era. Lancet Infect Dis. 2021 Jan;21(1):e11-e16. PubMed PMID: 33007225
  • Molina KC, Miller MA, Mueller SW, Van Matre ET, Krsak M, Kiser TH. Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin. Clin Pharmacokinet. 2021 Dec 21. [Epub ahead of print] PubMed PMID: 34931283
  • Krsak M, Harry BL, Palmer BE, Franco-Paredes C. Response to Mishra et al . re "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2". Viral Immunol. 2021 Nov;34(9):659-660. PubMed PMID: 34672802
  • Viszlayová D, Sojka M, Dobrodenková S, Szabó S, Bilec O, Turzová M, Durina J, Baloghová B, Borbély Z, Kršák M. SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVID. Ther Adv Infect Dis. 2021 Jan-Dec;8:20499361211048572. PubMed PMID: 34659752
  • Rosolanka R, Henao-Martinez AF, Pisney L, Franco-Paredes C, Krsak M. COVID-19: a review of current knowledge regarding exposure, quarantine, isolation and other preventive measures. Ther Adv Infect Dis. 2021 Jan-Dec;8:20499361211032039. PubMed PMID: 34349986
  • Krsak M, Harry BL, Palmer BE, Franco-Paredes C. Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2. Viral Immunol. 2021 Oct;34(8):504-509. PubMed PMID: 34227891
  • Krsak M, Wada NI, Plankey MW, Kinney GL, Epeldegui M, Okafor CN, Friedman MR, Palella FJ, Erlandson KM. Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV. Cannabis Cannabinoid Res. 2021 Apr;6(2):165-173. PubMed PMID: 33912681
  • Mueller SW, Kedzior SK, Miller MA, Reynolds PM, Kiser TH, Krsak M, Molina KC. An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections. Expert Opin Pharmacother. 2021 Jul;22(10):1355-1371. PubMed PMID: 33878996
  • Quan NG, Latif H, Krsak M, Corbisiero MF, Solis J, Wand T, Mortaji P, Vrolijk MA, Kon S, Ghandnoosh N, Franco-Paredes C. Benefits of COVID-19 viral screening of formerly incarcerated individuals during community reentry. Ther Adv Infect Dis. 2021 Jan-Dec;8:2049936120985951. PubMed PMID: 33505680
  • Krsak M, Henao-Martínez AF, Franco-Paredes C. COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies. Viral Immunol. 2021 Apr;34(3):130-133. PubMed PMID: 33181055
  • Franco-Paredes C, Ghandnoosh N, Latif H, Krsak M, Henao-Martinez AF, Robins M, Vargas Barahona L, Poeschla EM. Decarceration and community re-entry in the COVID-19 era. Lancet Infect Dis. 2021 Jan;21(1):e11-e16. PubMed PMID: 33007225
  • Krsak M, Damioli L. Is 2 Weeks of Treatment Enough for Cortical Bone Osteomyelitis?. Clin Infect Dis. 2020 Jan 1;70(1):179. PubMed PMID: 31069382
  • Krsak M, Montague BT, Trowbridge P, Johnson SC, Binswanger IA. Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. J Infect Dis. 2020 Sep 2;222(Supplement_5):S486-S493. PubMed PMID: 32877543
  • Krsak M, Morrisette T, Miller M, Molina K, Huang M, Damioli L, Pisney L, Wong M, Poeschla E. Advantages of Outpatient Treatment with Long-Acting Lipoglycopeptides for Serious Gram-Positive Infections: A Review. Pharmacotherapy. 2020 May;40(5):469-478. PubMed PMID: 32239771
  • Franco-Paredes C, Jankousky K, Schultz J, Bernfeld J, Cullen K, Quan NG, Kon S, Hotez P, Henao-Martínez AF, Krsak M. COVID-19 in jails and prisons: A neglected infection in a marginalized population. PLoS Negl Trop Dis. 2020 Jun;14(6):e0008409. PubMed PMID: 32569274
  • Krsak M, Johnson SC, Poeschla EM. COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions. Am J Trop Med Hyg. 2020 Jun;102(6):1189-1190. PubMed PMID: 32329432
  • Krsak M, Henao-Martínez AF, Franco-Paredes C. Screening for Covid-19 in Skilled Nursing Facilities. N Engl J Med. 2020 Jul 9;383(2):190-191. PubMed PMID: 32469480
  • Canfield GS, Schultz JS, Windham S, Scherger S, Henao-Martinez AF, Shapiro L, Franco-Paredes C, Chastain DB, Wand T, Krsak M. Empiric Therapies for COVID-19: Destined to Fail by Ignoring the Lessons of History. J Hosp Med. 2020 Jul 1;15(7):434-436. PubMed PMID: 32584243
  • Solis J, Franco-Paredes C, Henao-Martínez AF, Krsak M, Zimmer SM. Structural Vulnerability in the U.S. Revealed in Three Waves of COVID-19. Am J Trop Med Hyg. 2020 Jul;103(1):25-27. PubMed PMID: 32383432
  • Krsak M, Wada NI, Plankey MW, Kinney GL, Epeldegui M, Okafor CN, Friedman MR, Palella FJ, Erlandson KM. Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV. Cannabis and Cannabinoid Research http://doi.org/10.1089/can.2019.0083 [Online ahead of print – 3/24/2020]
  • Krsak M, Henao-Martínez AF, Franco-Paredes C. COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies. Viral Immunology. (Online Ahead of Print: November 11, 2020), http://doi.org/10.1089/vim.2020.0246
  • Franco-Paredes C, Ghandnoosh N, Latif H, Krsak M, Henao-Martinez AF, Robins M, Vargas Barahona L, Poeschla EM. Decarceration and community re-entry in the COVID-19 era. Lancet Infect Dis. 2020 Sep 29:S1473-3099(20)30730-1. doi: 10.1016/S1473-3099(20)30730-1. Epub ahead of print. PMID: 33007225; PMCID: PMC7524519.
  • Krsak M, Henao-Martínez AF, Franco-Paredes C. COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies. Viral Immunol. 2020 Nov 11. [Epub ahead of print] PubMed PMID: 33181055
  • Krsak M, Montague BT, Trowbridge P, Johnson SC, Binswanger IA. Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. J Infect Dis. 2020 Sep 2;222(Supplement_5):S486-S493. PubMed PMID: 32877543
  • Canfield GS, Schultz JS, Windham S, Scherger S, Henao-Martinez AF, Shapiro L, Franco-Paredes C, Chastain DB, Wand T, Krsak M. Empiric Therapies for COVID-19: Destined to Fail by Ignoring the Lessons of History. J Hosp Med. 2020 Jul 1;15(7):434-436. PubMed PMID: 32584243
  • Franco-Paredes C, Jankousky K, Schultz J, Bernfeld J, Cullen K, Quan NG, Kon S, Hotez P, Henao-Martínez AF, Krsak M. COVID-19 in jails and prisons: A neglected infection in a marginalized population. PLoS Negl Trop Dis. 2020 Jun;14(6):e0008409. PubMed PMID: 32569274
  • Krsak M, Henao-Martínez AF, Franco-Paredes C. Screening for Covid-19 in Skilled Nursing Facilities. N Engl J Med. 2020 Jul 9;383(2):190-191. PubMed PMID: 32469480
  • Solis J, Franco-Paredes C, Henao-Martínez AF, Krsak M, Zimmer SM. Structural Vulnerability in the U.S. Revealed in Three Waves of COVID-19. Am J Trop Med Hyg. 2020 Jul;103(1):25-27. PubMed PMID: 32383432
  • Krsak M, Johnson SC, Poeschla EM. COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions. Am J Trop Med Hyg. 2020 Jun;102(6):1189-1190. PubMed PMID: 32329432
  • Krsak M, Morrisette T, Miller M, Molina K, Huang M, Damioli L, Pisney L, Wong M, Poeschla E. Advantages of Outpatient Treatment with Long-Acting Lipoglycopeptides for Serious Gram-Positive Infections: A Review. Pharmacotherapy. 2020 May;40(5):469-478. PubMed PMID: 32239771
  • Krsak M, Jeffers A, Shah J, Johnson SC, Montague BT. Access to Specialty Services: Opportunities for Expansion of Telemedicine to Support Correctional Health Care in Colorado. Telemed J E Health. 2020 Jun;26(6):776-783. PubMed PMID: 31486710
  • Krsak M, Damioli L. Is 2 Weeks of Treatment Enough for Cortical Bone Osteomyelitis?. Clin Infect Dis. 2020 Jan 1;70(1):179. PubMed PMID: 31069382
  • Krsak M, Wada NI, Plankey MW, Kinney GL, Epeldegui M, Okafor CN, Friedman MR, Palella FJ, Erlandson KM. Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV. Cannabis and Cannabinoid Research http://doi.org/10.1089/can.2019.0083 [Online ahead of print – 3/24/2020]
  • Krsak M, Patel NU, Poeschla EM. Case Report: Hepatic Fascioliasis in a Young Afghani Woman with Severe Wheezing, High-Grade Peripheral Eosinophilia, and Liver Lesions: A Brief Literature Review. Am J Trop Med Hyg. 2019 Mar;100(3):588-590. PubMed PMID: 30628571
  • Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use Drugs. Open Forum Infect Dis. 2019 Jul;6(7):ofz274. PubMed PMID: 31281868
  • Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections. J Antimicrob Chemother. 2019 Aug 1;74(8):2405-2416. PubMed PMID: 31322694
  • Krsak M, Jeffers A, Shah J, Johnson SC, Montague BT. Access to Specialty Services: Opportunities for Expansion of Telemedicine to Support Correctional Health Care in Colorado. Telemed J E Health. 2019 Sep 5. [Epub ahead of print] PubMed PMID: 31486710
  • Krsak M, Trowbridge P, Regan N, Freedman KI (2017) Buprenorphine with, or without, Naloxone for Pregnant Women?–Review of Current Evidence and Practice in Massachusetts. J Alcohol Drug Depend 5: 269
  • Krsak M, Kent DM, Terrin N, Holcroft C, Skinner SC, Wanke C. Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on Statins. AIDS Patient Care STDS. 2015 Jun;29(6):307-13. PubMed PMID: 25855882
View All (39 Total) View Less

Practice Locations

UCHealth Infectious Disease Clinic - Anschutz Medical Campus
1635 Aurora Ct
7th Floor
Aurora, CO 80045
720-848-0191

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Internal Medicine, Board Certification (2011, 2011)
  • Infectious Disease, Board Certification (2013, 2013)
  • Addiction Medicine, Board Certification (2018, 2018)
  • DATA 2000 Waiver, Specialized Training (2015)
Conditions & Treatments
  • Infections
  • Substance Abuse
Clinical Interests
HIV, viral hepatitis and other infections in patients with substance use disorders; telemedicine; correctional healthcare; COVID-19

Care Philosophy
Diseases interact with unique individuals - and that's how the general knowledge should be applied to patients, in an individualized fashion.

Public Speaking
Yes
1. HIV, hepatitis C and injection drug use. 2. Co-Management of Infectious Diseases and Addiction. 3. Substance Use Associated Risk and Risk/Harm Reduction Strategies 4. HIV, Hepatitis C and Pre-Exposure Prophylaxis (PrEP) Overview 5. COVID-19 topics 6. Telemedicine in Infectious Diseases and Addiction Medicine 7. Correctional Healthcare topics 8. Long-acting medications in Infectious Diseases and Addiction Medicine

General Information

Medical Schools:
  • MD, Comenius University School of Medicine (2005)
Graduate Schools:
  • MSc, Tufts University (2014)
Internships:
  • Caritas Carney Hospital Program (2009)
Residency Programs:
  • Caritas Carney Hospital Program, Internal Medicine (2011)
Fellowships:
  • Tufts Medical Center Program, Infectious Disease (2014)
Department: Medicine-Infectious Disease
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;